Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Invested Capital: 2020-2025

Historic Invested Capital for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to -$2.6 million.

  • Biofrontera's Invested Capital fell 146.67% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 146.67%. This contributed to the annual value of $4.4 million for FY2024, which is 49.03% down from last year.
  • As of Q3 2025, Biofrontera's Invested Capital stood at -$2.6 million, which was up 44.71% from -$4.7 million recorded in Q2 2025.
  • Biofrontera's 5-year Invested Capital high stood at $30.8 million for Q4 2022, and its period low was -$17.4 million during Q3 2021.
  • Over the past 3 years, Biofrontera's median Invested Capital value was $5.0 million (recorded in 2024), while the average stood at $5.2 million.
  • Per our database at Business Quant, Biofrontera's Invested Capital spiked by 248.66% in 2022 and then crashed by 146.67% in 2025.
  • Over the past 5 years, Biofrontera's Invested Capital (Quarterly) stood at $14.6 million in 2021, then skyrocketed by 111.39% to $30.8 million in 2022, then tumbled by 71.78% to $8.7 million in 2023, then crashed by 49.03% to $4.4 million in 2024, then plummeted by 146.67% to -$2.6 million in 2025.
  • Its Invested Capital stands at -$2.6 million for Q3 2025, versus -$4.7 million for Q2 2025 and $500,000 for Q1 2025.